SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-222290
Filing Date
2013-05-15
Accepted
2013-05-15 16:01:32
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d516132d10q.htm 10-Q 584605
2 EX-10.1 d516132dex101.htm EX-10.1 493739
3 EX-31.1 d516132dex311.htm EX-31.1 6663
4 EX-31.2 d516132dex312.htm EX-31.2 6676
5 EX32.1 d516132dex321.htm EX-32.1 4557
  Complete submission text file 0001193125-13-222290.txt   3761589

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT celphap-20130331.xml EX-101.INS 391350
7 XBRL TAXONOMY EXTENSION SCHEMA celphap-20130331.xsd EX-101.SCH 35050
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celphap-20130331_cal.xml EX-101.CAL 55866
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celphap-20130331_def.xml EX-101.DEF 116611
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE celphap-20130331_lab.xml EX-101.LAB 282117
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celphap-20130331_pre.xml EX-101.PRE 185371
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54852 | Film No.: 13846854
SIC: 2834 Pharmaceutical Preparations